Circulating Tumor Cell Count Correlates with Colorectal Neoplasm Progression and Is a Prognostic Marker for Distant Metastasis in Non-Metastatic Patients

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Tsai, Wen Sy ^a,b   Chen, Jinn Shiun ^a,b   Shao, Hung Jen ^c,e   Wu, Jen Chia ^c   Lai, Jr Ming ^c   Lu, Si Hong ^c,d   Hung, Tsung Fu ^c   Chiu, Yen Chi ^c   You, Jeng Fu ^a   Hsieh, Pao Shiu ^a   Yeh, Chien Yuh ^a   Hung, Hsin Yuan ^a   Chiang, Sum Fu ^a   Lin, Geng Ping ^a   Tang, Reiping ^a   Chang, Ying Chih ^c,d  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c GENOMICS RESEARCH CENTER   (Taiwan)

^d NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^e NONE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CELL COUNT; COLORECTAL NEOPLASMS; DEVICES; EVALUATION STUDY; FEMALE; HUMAN; MALE; MICROFLUIDICS; MIDDLE AGED; NEOPLASM METASTASIS; PATHOLOGY; PROCEDURES; PROGNOSIS; TUMOR EMBOLISM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CELL COUNT; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MICROFLUIDICS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS;

EID: 84963801115     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep24517     Document Type: Article

References (22)

1. Chiang, C. J. et al. Cancer trends in Taiwan. Jpn J Clin Oncol 40, 897-904, doi: 10.1093/jjco/hyq057 (2010).
2. Torino, F. et al. Circulating tumor cells in colorectal cancer patients. Cancer Treat Rev 39, 759-772, doi: 10.1016/j.ctrv.2012.12.007 (2013).
3. Siegel, R. L., Miller, K. D. & Jemal A. Cancer statistics, 2016. CA Cancer J Clin 66(1):7-30, doi: 10.3322/caac.21332.
4. Muthukkaruppan, V. R., Kubai, L. & Auerbach, R. Tumor-induced neovascularization in the mouse eye. J Natl Cancer Inst 69, 699-708 (1982).
5. Glaves, D. Correlation between circulating cancer cells and incidence of metastases. Br J Cancer 48, 665-673 (1983).
6. Cohen, S. J. et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. Journal of clinical oncology : J Clin Oncol 26, 3213-3221, doi: 10.1200/JCO.2007.15.8923 (2008).
7. Sastre, J. et al. Circulating tumor cells in colorectal cancer: correlation with clinical and pathological variables. Ann Oncol 19, 935-938, doi: 10.1093/annonc/mdm583 (2008).
8. Bork, U. et al. Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study. Br J Cancer 112, 1306-1313, doi: 10.1038/bjc.2015.88 (2015).
9. Thorsteinsson, M., Soletormos, G. & Jess, P. Low number of detectable circulating tumor cells in non-metastatic colon cancer. Anticancer Res 31, 613-617 (2011).
10. Wu, J. C. et al. Antibody conjugated supported lipid bilayer for capturing and purification of viable tumor cells in blood for subsequent cell culture. Biomaterials 34, 5191-5199, doi: 10.1016/j.biomaterials.2013.03.096 (2013).
11. Lai, J. M., Shao, H. J., Wu, J. C., Lu, S. H. & Chang, Y. C. Efficient elusion of viable adhesive cells from a microfluidic system by air foam. Biomicrofluidics 8, 052001, doi: 10.1063/1.4893348 (2014).
12. Chen, J. Y. et al. Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection. PloS ONE 11, e0149633, doi: 10.1371/journal.pone.0149633 (2016).
13. Lu, S. H. et al. Identifying Cancer Origin Using Circulating Tumor Cells. Cancer Biol Ther, 0, doi: 10.1080/15384047.2016.1141839 (2016).
14. Small, A. C. et al. The emerging role of circulating tumor cell detection in genitourinary cancer. J Urol 188, 21-26, doi: 10.1016/j. juro.2012.02.2558 (2012).
15. Bidard, F. C. et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. Lancet Oncol 15, 406-414, doi: 10.1016/S1470-2045(14)70069-5 (2014).
16. Chu, P., Wu, E. & Weiss, L. M. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 13, 962-972, doi: 10.1038/modpathol.3880175 (2000).
17. Welinder, C., Jansson, B., Lindell, G. & Wenner, J. Cytokeratin 20 improves the detection of circulating tumor cells in patients with colorectal cancer. Cancer Lett 358, 43-46, doi: 10.1016/j.canlet.2014.12.024 (2015).
18. Ratto, C. et al. Prognostic factors in colorectal cancer. Literature review for clinical application. Dis Colon Rectum 41, 1033-1049 (1998).
19. McArdle, C. S., McMillan, D. C. & Hole, D. J. The impact of blood loss, obstruction and perforation on survival in patients undergoing curative resection for colon cancer. Br J Surg 93, 483-488, doi: 10.1002/bjs.5269 (2006).
20. Kunihiro, M. et al. Electrocautery snare resection stimulates cellular proliferation of residual colorectal tumor: an increasing gene expression related to tumor growth. Dis Colon Rectum 43, 1107-1115 (2000).
21. Pantel, K. et al. Circulating epithelial cells in patients with benign colon diseases. Clin Chem 58, 936-940, doi: 10.1373/clinchem.2011.175570 (2012).
22. Galizia, G. et al. Postoperative detection of circulating tumor cells predicts tumor recurrence in colorectal cancer patients. J Gastrointest Surg 17, 1809-1818, doi: 10.1007/s11605-013-2258-6 (2013).